Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.46 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.46 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.46 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.46 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.46 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.46 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.46 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7417712 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP3A4TSHRHTTPIK3CD | |
| SCHEMBL9153465 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP3A4TSHRHTTPIK3CD | |
| SCHEMBL18780344 | 0.93 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TSHRHTTPIK3CD | |
| SCHEMBL17329200 | 0.86 | MEN1 (0.56) | ALDH1A1CYP3A4POLBMAPTKMT2A | |
| SCHEMBL17329201 | 0.86 | MEN1 (0.56) | ALDH1A1CYP3A4POLBMAPTKMT2A | |
| SCHEMBL18780379 | 0.85 | PIK3CD (0.45) | PIK3CDPIK3CBPIK3CG | |
| SCHEMBL20334896 | 0.85 | PIK3CD (0.45) | PIK3CDPIK3CBPIK3CG | |
| SCHEMBL17329225 | 0.85 | PIK3CD (0.46) | PIK3CDPIK3CBPIK3CG | |
| SCHEMBL17329197 | 0.85 | PIK3CD (0.46) | PIK3CDPIK3CBPIK3CG | |
| SCHEMBL8839698 | 0.85 | CRHBP (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1193253-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORP (JP) | 2008-06-25 | — | — | EP | disclosed |
| EP-1927588-A2 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2008-06-04 | — | — | EP | disclosed |
| US-7262308-B2 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20050043547-A1 | Process for producing optically active azetidine-2-carboxylic acids | HONDA TATSUYA (JP) | 2005-02-24 | — | — | US | disclosed |
| US-6838567-B1 | Process for producing optically active azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2005-01-04 | — | — | US | disclosed |
| US-20040171849-A1 | Process for producing optically active azetidine-2-carboxylic acid | KANEKA CORPORATION (JP) | 2004-09-02 | — | — | US | disclosed |
| EP-1415985-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACID | KANEKA CORPORATION (JP) | 2004-05-06 | — | — | EP | disclosed |
| CN-1125064-C | 3-pyridyl enantiomers and their use as analgesics | ABBOTT LAB (US) | 2003-10-22 | — | — | CN | disclosed |
| EP-0992491-B1 | PROCESSES FOR PRODUCING AZETIDINE-2-CARBOXYLIC ACID AND INTERMEDIATES THEREOF | KANEKA CORP (JP) | 2003-03-05 | — | — | EP | disclosed |
| EP-0950057-B1 | 3-PYRIDYL ENANTIOMERS AND THEIR USE AS ANALGESICS | ABBOTT LAB (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6432975-B1 | AROMATIC ALKYLENE AZOBICYCLIC COMPOUNDS AS NICOTINIC RECEPTOR ANTAGONISTS; ANTIDEPRESSANTS; NERVOUS SYSTEM DISORDER TREATMENT | TARGACEPT, INC. | 2002-08-13 | — | — | US | disclosed |
| US-6403575-B1 | ANTI-INFLAMMATORIES | ABBOTT LABORATORIES | 2002-06-11 | — | — | US | disclosed |
| EP-1193253-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORPORATION (JP) | 2002-04-03 | — | — | EP | disclosed |
| US-6150535-A | Processes for producing azetidine-2-carboxylic acid and intermediates thereof | KANEKA CORPORATION (JP) | 2000-11-21 | — | — | US | disclosed |
| EP-1047690-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | Abbott Laboratories (US) | 2000-11-02 | — | — | EP | disclosed |
| US-6133253-A | NEURONAL CELL DEATH PREVENTORS AND ANTI-INFLAMMATORIES | ABBOTT LABORATORIES (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0992491-A1 | PROCESSES FOR PRODUCING AZETIDINE-2-CARBOXYLIC ACID AND INTERMEDIATES THEREOF | KANEKA CORPORATION (JP) | 2000-04-12 | — | — | EP | disclosed |
| CN-1245496-A | 3-pyridyl enantiomers and their use as analgesics | ABBOTT LAB (US) | 2000-02-23 | — | — | CN | disclosed |
| WO-1999032480-A1 | HETEROCYCLIC ETHER AND THIOETHER COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION | ABBOTT LABORATORIES (US) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171849-A1 | Process for producing optically active azetidine-2-carboxylic acid | HBB, ADCY2, ADCY9 | ALDH1A1 587/4885CYP3A4 526/4885TSHR 1514/4885 |
| US-20050043547-A1 | Process for producing optically active azetidine-2-carboxylic acids | AZI2, ALAD, HBB | ALDH1A1 1133/4885CYP3A4 339/4885TSHR 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.